Impact Biomedical Inc. (NYSEAMERICAN:IBO) Stock Short Interest Drops 94.3%

Impact Biomedical Inc. (NYSEAMERICAN:IBO) was the recipient of a large decline in short interest during the month of September. As of September 30th, there was short interest totaling 30,169 shares, a decline of 94.3% from the September 15th total of 526,986 shares. Currently, 3.2% of the company’s stock are sold short. Based on an average trading volume of 15,208 shares, the days-to-cover ratio is presently 2.0 days.

Impact Biomedical Stock Performance

Shares of NYSEAMERICAN IBO traded up $0.14 during trading on Friday, hitting $4.25. The stock had a trading volume of 4,014 shares, compared to its average volume of 14,890. The firm has a fifty day moving average of $5.79 and a two-hundred day moving average of $6.60. Impact Biomedical has a 12 month low of $4.06 and a 12 month high of $10.47.

Impact Biomedical (NYSEAMERICAN:IBO) last released its quarterly earnings results on Friday, August 7th. The company reported ($0.13) earnings per share for the quarter. Impact Biomedical had a net margin of 2,254.28% and a return on equity of 8.81%. The firm had revenue of $0.00 million for the quarter.

About Impact Biomedical

Impact Biomedical, Inc is a biotechnology and life sciences company focused on developing and commercializing biomedical technologies, pharmaceutical products and related health solutions. Its activities have included research into antiviral, antimicrobial and anti-inflammatory applications, with an emphasis on technologies intended to address infectious diseases and other public health needs.

The company has described a portfolio of biomedical intellectual property and development programs rather than a broad portfolio of established commercial products.